Zawistowski, J. S., Bevill, S. M., Goulet, D. R., Stuhlmiller, T. J., Beltran, A. S., Olivares-Quintero, J. F., . . . Johnson, G. L. (2017). Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacological Targeting of the P-TEFb Complex. Cancer Discov.
Chicago Style citaatZawistowski, Jon S., et al. "Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated By Pharmacological Targeting of the P-TEFb Complex." Cancer Discov 2017.
MLA citatieZawistowski, Jon S., et al. "Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated By Pharmacological Targeting of the P-TEFb Complex." Cancer Discov 2017.
Let op: Deze citaties zijn niet altijd 100% accuraat.